Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Share News (AMYT)

  • There is currently no data for AMYT

AMYT.L News

Cathal Friel-led Poolbeg Pharma set to float on AIM
17 Jun 2021

Cathal Friel-led Poolbeg Pharma set to float on AIM

(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising t...

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall
3 Jun 2021

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

BUSINESS UPDATES: HSBC issues notes; discoverIE reports profit fall

FDA grants Amryt's Oleogel-S10 priority review status
3 Jun 2021

FDA grants Amryt's Oleogel-S10 priority review status

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma announced on Thursday that the United States Food and Drug Administration (...

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows
2 Jun 2021

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

TRADING UPDATES: Block Energy 2020 revenue jumps; Kanabo loss narrows

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million
5 May 2021

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

TRADING UPDATES: SIG in good start to 2021; Accsys taps EUR37 million

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start
6 Apr 2021

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

EXECUTIVE CHANGES: Rosslyn promotes new CEO; Celtic CEO ready to start

Amryt completes rolling FDA submission for Oleogel-S10
31 Mar 2021

Amryt completes rolling FDA submission for Oleogel-S10

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma has completed the rolling submission of a new drug application (NDA) to the...

Amryt releases data from Italy lomitapide study
30 Mar 2021

Amryt releases data from Italy lomitapide study

(Sharecast News) - Commercial-stage biopharmaceutical company Amryt Pharma released efficacy and safety data from the 'Lochnes' investigator-sponsored...